Compounders Gain Flexibility In Quality Standards Due To PPE Shortages
Executive Summary
The US FDA will allow pharmacy compounders to use non-sterile masks and gloves in cleanrooms, but risk strategies must be in place to ensure products are as contaminant-free as possible. Discretion responds to the current shortage of protective gear due to the COVID-19 pandemic.
You may also be interested in...
Second EUA For Mask Decontamination Tech Goes To Steris
The US FDA has issued an emergency use authorization permitting the Steris V-PRO to be used to decontaminate masks used by medical professionals during the COVID-19 pandemic. The technology could get as many as 750,000 more clean N95 masks to medical personnel each day, the agency says.
The FDA Aims To Strike Balance On Inspecting Physicians Who Compound Drugs
Just how much will the FDA look the other way when it comes to inspecting physician compounders?
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”